

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 6.16209529 |
| 2 | regulation of glucokinase activity (GO:0033131) | 5.98620434 |
| 3 | regulation of hexokinase activity (GO:1903299) | 5.98620434 |
| 4 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.74588284 |
| 5 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.61048190 |
| 6 | response to pheromone (GO:0019236) | 5.38236500 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 5.37758363 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 5.37758363 |
| 9 | L-fucose catabolic process (GO:0042355) | 5.05897142 |
| 10 | fucose catabolic process (GO:0019317) | 5.05897142 |
| 11 | L-fucose metabolic process (GO:0042354) | 5.05897142 |
| 12 | adult feeding behavior (GO:0008343) | 4.97997691 |
| 13 | detection of calcium ion (GO:0005513) | 4.86180363 |
| 14 | cellular ketone body metabolic process (GO:0046950) | 4.85747469 |
| 15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.80810385 |
| 16 | aggressive behavior (GO:0002118) | 4.80330942 |
| 17 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 4.75101731 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.69650289 |
| 19 | behavioral response to ethanol (GO:0048149) | 4.68866077 |
| 20 | exogenous drug catabolic process (GO:0042738) | 4.65899677 |
| 21 | positive regulation of mitochondrial fission (GO:0090141) | 4.59563910 |
| 22 | glycerophospholipid catabolic process (GO:0046475) | 4.54919481 |
| 23 | protein localization to cilium (GO:0061512) | 4.52947904 |
| 24 | negative regulation of gluconeogenesis (GO:0045721) | 4.50759061 |
| 25 | regulation of neurotransmitter uptake (GO:0051580) | 4.34542067 |
| 26 | startle response (GO:0001964) | 4.34399612 |
| 27 | ketone body metabolic process (GO:1902224) | 4.29256513 |
| 28 | neuron cell-cell adhesion (GO:0007158) | 4.24600893 |
| 29 | pigment granule transport (GO:0051904) | 4.22432426 |
| 30 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.17525929 |
| 31 | establishment of pigment granule localization (GO:0051905) | 4.11131847 |
| 32 | succinate metabolic process (GO:0006105) | 4.07448707 |
| 33 | nucleobase catabolic process (GO:0046113) | 4.01708394 |
| 34 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.00982124 |
| 35 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.00982124 |
| 36 | auditory receptor cell differentiation (GO:0042491) | 3.94903307 |
| 37 | endocrine pancreas development (GO:0031018) | 3.93059880 |
| 38 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.92915223 |
| 39 | detection of light stimulus involved in visual perception (GO:0050908) | 3.92915223 |
| 40 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.88503081 |
| 41 | synaptic vesicle exocytosis (GO:0016079) | 3.86082334 |
| 42 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.84508842 |
| 43 | activation of protein kinase A activity (GO:0034199) | 3.84255164 |
| 44 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.81808751 |
| 45 | phenylpropanoid metabolic process (GO:0009698) | 3.76757793 |
| 46 | melanosome transport (GO:0032402) | 3.73940262 |
| 47 | drug catabolic process (GO:0042737) | 3.69747748 |
| 48 | protein K6-linked ubiquitination (GO:0085020) | 3.69624253 |
| 49 | pigment granule localization (GO:0051875) | 3.68477722 |
| 50 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.68078553 |
| 51 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.68078553 |
| 52 | synaptic transmission, dopaminergic (GO:0001963) | 3.67747198 |
| 53 | glandular epithelial cell development (GO:0002068) | 3.64695539 |
| 54 | establishment of melanosome localization (GO:0032401) | 3.64330209 |
| 55 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.63450886 |
| 56 | type B pancreatic cell development (GO:0003323) | 3.62732125 |
| 57 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.61888945 |
| 58 | L-phenylalanine catabolic process (GO:0006559) | 3.61888945 |
| 59 | synaptic vesicle maturation (GO:0016188) | 3.61712259 |
| 60 | peptide hormone processing (GO:0016486) | 3.61241238 |
| 61 | regulation of beta-amyloid formation (GO:1902003) | 3.59429980 |
| 62 | gamma-aminobutyric acid transport (GO:0015812) | 3.59022821 |
| 63 | dopamine transport (GO:0015872) | 3.57559900 |
| 64 | locomotory exploration behavior (GO:0035641) | 3.53692767 |
| 65 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.53609468 |
| 66 | epithelial cell fate commitment (GO:0072148) | 3.52952791 |
| 67 | dicarboxylic acid catabolic process (GO:0043649) | 3.50345325 |
| 68 | nitric oxide mediated signal transduction (GO:0007263) | 3.49932499 |
| 69 | vocalization behavior (GO:0071625) | 3.49306954 |
| 70 | catecholamine transport (GO:0051937) | 3.47874271 |
| 71 | cellular response to glucagon stimulus (GO:0071377) | 3.43325262 |
| 72 | positive regulation of response to extracellular stimulus (GO:0032106) | 3.42962841 |
| 73 | positive regulation of response to nutrient levels (GO:0032109) | 3.42962841 |
| 74 | transferrin transport (GO:0033572) | 3.37945974 |
| 75 | positive regulation of amine transport (GO:0051954) | 3.35406961 |
| 76 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.34369973 |
| 77 | regulation of response to food (GO:0032095) | 3.31374154 |
| 78 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.30581250 |
| 79 | regulation of synaptic vesicle transport (GO:1902803) | 3.24103038 |
| 80 | melanosome localization (GO:0032400) | 3.23798966 |
| 81 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.22084273 |
| 82 | xenobiotic catabolic process (GO:0042178) | 3.22008009 |
| 83 | trivalent inorganic cation transport (GO:0072512) | 3.21854173 |
| 84 | ferric iron transport (GO:0015682) | 3.21854173 |
| 85 | regulation of mitochondrial fission (GO:0090140) | 3.21694956 |
| 86 | exploration behavior (GO:0035640) | 3.19210419 |
| 87 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.18303223 |
| 88 | insulin secretion (GO:0030073) | 3.16798577 |
| 89 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.16631799 |
| 90 | positive regulation of insulin secretion (GO:0032024) | 3.14926220 |
| 91 | peptidyl-cysteine modification (GO:0018198) | 3.12919886 |
| 92 | intraciliary transport (GO:0042073) | 3.12720265 |
| 93 | parturition (GO:0007567) | 3.11371060 |
| 94 | neurotransmitter secretion (GO:0007269) | 3.11366264 |
| 95 | phagosome maturation (GO:0090382) | 3.10356553 |
| 96 | positive regulation of amino acid transport (GO:0051957) | 3.08820755 |
| 97 | positive regulation of membrane potential (GO:0045838) | 3.08717569 |
| 98 | neurotransmitter uptake (GO:0001504) | 3.06955831 |
| 99 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.06785539 |
| 100 | glandular epithelial cell differentiation (GO:0002067) | 3.06234871 |
| 101 | positive regulation of action potential (GO:0045760) | 3.06198469 |
| 102 | protein localization to synapse (GO:0035418) | 3.05828652 |
| 103 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.04030938 |
| 104 | innervation (GO:0060384) | 3.03600976 |
| 105 | oxaloacetate metabolic process (GO:0006107) | 3.00150965 |
| 106 | cerebellar Purkinje cell layer development (GO:0021680) | 2.98207390 |
| 107 | NADH metabolic process (GO:0006734) | 2.97532369 |
| 108 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.97151207 |
| 109 | norepinephrine metabolic process (GO:0042415) | 2.97056649 |
| 110 | negative regulation of telomere maintenance (GO:0032205) | 2.96675711 |
| 111 | regulation of insulin secretion (GO:0050796) | 2.95829080 |
| 112 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.95354339 |
| 113 | regulation of mitochondrial translation (GO:0070129) | 2.95129136 |
| 114 | protein-cofactor linkage (GO:0018065) | 2.94918861 |
| 115 | regulation of vesicle fusion (GO:0031338) | 2.94612392 |
| 116 | plasma membrane fusion (GO:0045026) | 2.94396557 |
| 117 | L-phenylalanine metabolic process (GO:0006558) | 2.94182412 |
| 118 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.94182412 |
| 119 | calcium ion import (GO:0070509) | 2.93714311 |
| 120 | cellular response to ammonium ion (GO:0071242) | 2.93642489 |
| 121 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.93389712 |
| 122 | neuron-neuron synaptic transmission (GO:0007270) | 2.93085648 |
| 123 | negative regulation of receptor activity (GO:2000272) | 2.92746371 |
| 124 | negative regulation of neurotransmitter transport (GO:0051589) | 2.91495728 |
| 125 | positive regulation of exocytosis (GO:0045921) | 2.91184854 |
| 126 | dentate gyrus development (GO:0021542) | 2.89345679 |
| 127 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 2.89246848 |
| 128 | neurotransmitter biosynthetic process (GO:0042136) | 2.88854523 |
| 129 | neuromuscular process controlling posture (GO:0050884) | 2.86974062 |
| 130 | regulation of exocytosis (GO:0017157) | 2.86332437 |
| 131 | regulation of peptide hormone secretion (GO:0090276) | 2.84064218 |
| 132 | uterus development (GO:0060065) | 2.83932989 |
| 133 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.82591290 |
| 134 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.82190019 |
| 135 | ER overload response (GO:0006983) | 2.81678558 |
| 136 | negative regulation of peptide hormone secretion (GO:0090278) | 2.81356905 |
| 137 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.81023155 |
| 138 | establishment of mitochondrion localization (GO:0051654) | 2.79483564 |
| 139 | transmission of nerve impulse (GO:0019226) | 2.79436851 |
| 140 | regulation of peptide secretion (GO:0002791) | 2.79154549 |
| 141 | vesicle coating (GO:0006901) | 2.78503489 |
| 142 | dendritic spine morphogenesis (GO:0060997) | 2.77789421 |
| 143 | chemosensory behavior (GO:0007635) | 2.76023167 |
| 144 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.75416153 |
| 145 | glutamate secretion (GO:0014047) | 2.75292397 |
| 146 | regulation of appetite (GO:0032098) | 2.74174075 |
| 147 | fucosylation (GO:0036065) | 2.73966395 |
| 148 | regulation of neurotransmitter levels (GO:0001505) | 2.73243535 |
| 149 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.72198098 |
| 150 | growth hormone secretion (GO:0030252) | 2.72177633 |
| 151 | glycosphingolipid biosynthetic process (GO:0006688) | 2.71893915 |
| 152 | synaptic transmission, glutamatergic (GO:0035249) | 2.71566288 |
| 153 | COPII vesicle coating (GO:0048208) | 2.71328276 |
| 154 | righting reflex (GO:0060013) | 2.71147803 |
| 155 | response to histamine (GO:0034776) | 2.71034869 |
| 156 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.70994089 |
| 157 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.70907015 |
| 158 | protein maturation by protein folding (GO:0022417) | 2.70879443 |
| 159 | negative regulation of peptide secretion (GO:0002792) | 2.70798015 |
| 160 | positive regulation of receptor recycling (GO:0001921) | 2.70248545 |
| 161 | neuronal action potential propagation (GO:0019227) | 2.69457646 |
| 162 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.68987186 |
| 163 | zinc ion homeostasis (GO:0055069) | 2.68827271 |
| 164 | positive regulation of neurotransmitter transport (GO:0051590) | 2.68482590 |
| 165 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.68132719 |
| 166 | proline transport (GO:0015824) | 2.67871187 |
| 167 | cochlea development (GO:0090102) | 2.67416306 |
| 168 | axoneme assembly (GO:0035082) | 2.67003336 |
| 169 | mitochondrial calcium ion transport (GO:0006851) | 2.66971821 |
| 170 | synapse assembly (GO:0007416) | 2.66197178 |
| 171 | platelet dense granule organization (GO:0060155) | 2.65421755 |
| 172 | genitalia morphogenesis (GO:0035112) | 2.64914675 |
| 173 | astrocyte differentiation (GO:0048708) | 2.63924961 |
| 174 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.62740273 |
| 175 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.62740273 |
| 176 | response to dietary excess (GO:0002021) | 2.62142741 |
| 177 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.61391779 |
| 178 | negative regulation of heart growth (GO:0061117) | 2.60900180 |
| 179 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.60900180 |
| 180 | positive regulation of peptide hormone secretion (GO:0090277) | 2.60279392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.49741041 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.36673795 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.65684905 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.29206421 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.88785473 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.74957125 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.61218843 |
| 8 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44773729 |
| 9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.43917305 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.42959524 |
| 11 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.37995245 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36756696 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.35691914 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.33997320 |
| 15 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.27167824 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.23791990 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.22309205 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.21976657 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.20077360 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.19787525 |
| 21 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.19468746 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.19362814 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.16946995 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.16946995 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.07391070 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.97254847 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.93017828 |
| 28 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.90655721 |
| 29 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.87135330 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.82198611 |
| 31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.81961226 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.78990159 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78454186 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.77171636 |
| 35 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.75862408 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.73286781 |
| 37 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.72032707 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71628871 |
| 39 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71368016 |
| 40 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.66294810 |
| 41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.63013688 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62184774 |
| 43 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59025934 |
| 44 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.57916552 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.55348714 |
| 46 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.55328014 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.53808858 |
| 48 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.53268418 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.52882071 |
| 50 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.51485598 |
| 51 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.50438028 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.49291571 |
| 53 | VDR_22108803_ChIP-Seq_LS180_Human | 1.46403855 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.43968161 |
| 55 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.43915886 |
| 56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.43365583 |
| 57 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.35592617 |
| 58 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.34735735 |
| 59 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.34406484 |
| 60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30191713 |
| 61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29805904 |
| 62 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29425810 |
| 63 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25410977 |
| 64 | EWS_26573619_Chip-Seq_HEK293_Human | 1.24963702 |
| 65 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23304498 |
| 66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22285910 |
| 67 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20264011 |
| 68 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.18459897 |
| 69 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18093935 |
| 70 | NCOR_22424771_ChIP-Seq_293T_Human | 1.16910513 |
| 71 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16673690 |
| 72 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16059501 |
| 73 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.15955527 |
| 74 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.13487566 |
| 75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13273320 |
| 76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13150854 |
| 77 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.11610658 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11191930 |
| 79 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11189979 |
| 80 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11189979 |
| 81 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10976714 |
| 82 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.10816308 |
| 83 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.09764679 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08250139 |
| 85 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07544704 |
| 86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.07325237 |
| 87 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06569749 |
| 88 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06267283 |
| 89 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06171943 |
| 90 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05860263 |
| 91 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05602381 |
| 92 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05445662 |
| 93 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05184960 |
| 94 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.04739500 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04265130 |
| 96 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.04013111 |
| 97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02041285 |
| 98 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.99550489 |
| 99 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99473805 |
| 100 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99090671 |
| 101 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98696158 |
| 102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98409653 |
| 103 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98409653 |
| 104 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96497464 |
| 105 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.96385173 |
| 106 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95966347 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95619594 |
| 108 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.94793086 |
| 109 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93775807 |
| 110 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.93385933 |
| 111 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92909115 |
| 112 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.91491546 |
| 113 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.91491546 |
| 114 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91347215 |
| 115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90744633 |
| 116 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90679685 |
| 117 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90408092 |
| 118 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90408092 |
| 119 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90386948 |
| 120 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89670424 |
| 121 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89225991 |
| 122 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.89142082 |
| 123 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.88262976 |
| 124 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.87917921 |
| 125 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87578281 |
| 126 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.86501766 |
| 127 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.86216307 |
| 128 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.86014673 |
| 129 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85890739 |
| 130 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.84172333 |
| 131 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.84137503 |
| 132 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.84054492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000013_abnormal_adipose_tissue | 5.33699579 |
| 2 | MP0005645_abnormal_hypothalamus_physiol | 4.93398054 |
| 3 | MP0003122_maternal_imprinting | 3.42210289 |
| 4 | MP0002909_abnormal_adrenal_gland | 3.10747407 |
| 5 | MP0003183_abnormal_peptide_metabolism | 3.09558810 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 2.98060347 |
| 7 | MP0004043_abnormal_pH_regulation | 2.68322943 |
| 8 | MP0001529_abnormal_vocalization | 2.62630065 |
| 9 | MP0005187_abnormal_penis_morphology | 2.48101756 |
| 10 | MP0001501_abnormal_sleep_pattern | 2.46876648 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.46105330 |
| 12 | MP0004147_increased_porphyrin_level | 2.44839692 |
| 13 | MP0010386_abnormal_urinary_bladder | 2.39275417 |
| 14 | MP0003787_abnormal_imprinting | 2.33554974 |
| 15 | * MP0003635_abnormal_synaptic_transmissio | 2.32030525 |
| 16 | MP0005379_endocrine/exocrine_gland_phen | 2.29701203 |
| 17 | MP0003195_calcinosis | 2.24719163 |
| 18 | MP0002064_seizures | 2.20420909 |
| 19 | MP0004270_analgesia | 2.16241603 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.15503733 |
| 21 | MP0000372_irregular_coat_pigmentation | 2.09780279 |
| 22 | MP0009046_muscle_twitch | 2.09472495 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.01930637 |
| 24 | * MP0002272_abnormal_nervous_system | 2.01788819 |
| 25 | MP0003283_abnormal_digestive_organ | 1.98103587 |
| 26 | MP0002693_abnormal_pancreas_physiology | 1.96393737 |
| 27 | MP0009745_abnormal_behavioral_response | 1.95391850 |
| 28 | MP0004885_abnormal_endolymph | 1.95199433 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 1.92509204 |
| 30 | MP0002638_abnormal_pupillary_reflex | 1.91872720 |
| 31 | MP0000003_abnormal_adipose_tissue | 1.88254940 |
| 32 | MP0003646_muscle_fatigue | 1.83975848 |
| 33 | MP0001188_hyperpigmentation | 1.82100419 |
| 34 | MP0002063_abnormal_learning/memory/cond | 1.80192841 |
| 35 | MP0002734_abnormal_mechanical_nocicepti | 1.79137183 |
| 36 | MP0001944_abnormal_pancreas_morphology | 1.78544342 |
| 37 | MP0008877_abnormal_DNA_methylation | 1.76745274 |
| 38 | MP0002928_abnormal_bile_duct | 1.70527135 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.69804288 |
| 40 | MP0004858_abnormal_nervous_system | 1.69414043 |
| 41 | MP0002090_abnormal_vision | 1.69002095 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.63789108 |
| 43 | MP0001986_abnormal_taste_sensitivity | 1.60644551 |
| 44 | MP0003959_abnormal_lean_body | 1.57950777 |
| 45 | MP0002735_abnormal_chemical_nociception | 1.54978901 |
| 46 | MP0004036_abnormal_muscle_relaxation | 1.53343520 |
| 47 | MP0004084_abnormal_cardiac_muscle | 1.52031116 |
| 48 | MP0002163_abnormal_gland_morphology | 1.48922704 |
| 49 | MP0001905_abnormal_dopamine_level | 1.46031705 |
| 50 | MP0002822_catalepsy | 1.43162833 |
| 51 | MP0002102_abnormal_ear_morphology | 1.42195065 |
| 52 | MP0008961_abnormal_basal_metabolism | 1.41703107 |
| 53 | MP0000639_abnormal_adrenal_gland | 1.40615751 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 1.38197421 |
| 55 | MP0001970_abnormal_pain_threshold | 1.36848376 |
| 56 | MP0001661_extended_life_span | 1.36735393 |
| 57 | MP0005253_abnormal_eye_physiology | 1.33948116 |
| 58 | MP0006276_abnormal_autonomic_nervous | 1.33657799 |
| 59 | MP0001968_abnormal_touch/_nociception | 1.32762114 |
| 60 | MP0003045_fibrosis | 1.32271328 |
| 61 | MP0002736_abnormal_nociception_after | 1.31983960 |
| 62 | MP0006292_abnormal_olfactory_placode | 1.31500151 |
| 63 | MP0004233_abnormal_muscle_weight | 1.29794563 |
| 64 | MP0003866_abnormal_defecation | 1.29398366 |
| 65 | MP0002557_abnormal_social/conspecific_i | 1.28173038 |
| 66 | MP0005646_abnormal_pituitary_gland | 1.27937618 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.27825215 |
| 68 | MP0003123_paternal_imprinting | 1.26674839 |
| 69 | MP0002733_abnormal_thermal_nociception | 1.26605097 |
| 70 | MP0003880_abnormal_central_pattern | 1.25390289 |
| 71 | MP0003121_genomic_imprinting | 1.24857605 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 1.23852176 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 1.23827283 |
| 74 | MP0005535_abnormal_body_temperature | 1.23763090 |
| 75 | MP0010329_abnormal_lipoprotein_level | 1.23305153 |
| 76 | MP0001485_abnormal_pinna_reflex | 1.21736458 |
| 77 | MP0003011_delayed_dark_adaptation | 1.20817317 |
| 78 | MP0003172_abnormal_lysosome_physiology | 1.20142847 |
| 79 | MP0003329_amyloid_beta_deposits | 1.17803937 |
| 80 | MP0006072_abnormal_retinal_apoptosis | 1.16691081 |
| 81 | MP0002229_neurodegeneration | 1.15871014 |
| 82 | MP0002184_abnormal_innervation | 1.13765153 |
| 83 | MP0005266_abnormal_metabolism | 1.12336779 |
| 84 | MP0002069_abnormal_eating/drinking_beha | 1.11872469 |
| 85 | MP0001984_abnormal_olfaction | 1.11240986 |
| 86 | MP0003136_yellow_coat_color | 1.09742029 |
| 87 | MP0001756_abnormal_urination | 1.09247322 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 1.08127902 |
| 89 | MP0004924_abnormal_behavior | 1.07475730 |
| 90 | MP0005386_behavior/neurological_phenoty | 1.07475730 |
| 91 | MP0001486_abnormal_startle_reflex | 1.07442546 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 1.06173978 |
| 93 | MP0003878_abnormal_ear_physiology | 1.06173978 |
| 94 | MP0002067_abnormal_sensory_capabilities | 1.04776510 |
| 95 | MP0004019_abnormal_vitamin_homeostasis | 1.03945224 |
| 96 | * MP0001664_abnormal_digestion | 1.02108494 |
| 97 | MP0000955_abnormal_spinal_cord | 1.01894358 |
| 98 | MP0001764_abnormal_homeostasis | 1.01059981 |
| 99 | MP0005448_abnormal_energy_balance | 0.99890039 |
| 100 | MP0001502_abnormal_circadian_rhythm | 0.99588796 |
| 101 | MP0005332_abnormal_amino_acid | 0.96933573 |
| 102 | MP0000678_abnormal_parathyroid_gland | 0.95827810 |
| 103 | MP0000631_abnormal_neuroendocrine_gland | 0.94785942 |
| 104 | MP0004811_abnormal_neuron_physiology | 0.94373705 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.93751262 |
| 106 | MP0003879_abnormal_hair_cell | 0.91508697 |
| 107 | MP0000750_abnormal_muscle_regeneration | 0.91162274 |
| 108 | MP0005257_abnormal_intraocular_pressure | 0.90615349 |
| 109 | MP0004085_abnormal_heartbeat | 0.87607393 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.85249982 |
| 111 | MP0003953_abnormal_hormone_level | 0.83479942 |
| 112 | MP0002066_abnormal_motor_capabilities/c | 0.83455143 |
| 113 | MP0000778_abnormal_nervous_system | 0.82505993 |
| 114 | MP0000230_abnormal_systemic_arterial | 0.82422992 |
| 115 | MP0004134_abnormal_chest_morphology | 0.81852989 |
| 116 | MP0008872_abnormal_physiological_respon | 0.80799387 |
| 117 | MP0003567_abnormal_fetal_cardiomyocyte | 0.80470600 |
| 118 | MP0005174_abnormal_tail_pigmentation | 0.80339309 |
| 119 | MP0000751_myopathy | 0.79308758 |
| 120 | MP0003119_abnormal_digestive_system | 0.77899707 |
| 121 | MP0001963_abnormal_hearing_physiology | 0.76814489 |
| 122 | MP0005220_abnormal_exocrine_pancreas | 0.76265539 |
| 123 | MP0008995_early_reproductive_senescence | 0.74778265 |
| 124 | MP0002882_abnormal_neuron_morphology | 0.73157855 |
| 125 | MP0004142_abnormal_muscle_tone | 0.72848500 |
| 126 | MP0008569_lethality_at_weaning | 0.71211214 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.71150027 |
| 128 | MP0005670_abnormal_white_adipose | 0.69525235 |
| 129 | MP0008775_abnormal_heart_ventricle | 0.68767978 |
| 130 | MP0002896_abnormal_bone_mineralization | 0.67997371 |
| 131 | MP0005058_abnormal_lysosome_morphology | 0.67513978 |
| 132 | MP0003633_abnormal_nervous_system | 0.67407736 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.67368440 |
| 134 | MP0002234_abnormal_pharynx_morphology | 0.65972484 |
| 135 | MP0004264_abnormal_extraembryonic_tissu | 0.65348072 |
| 136 | MP0004883_abnormal_blood_vessel | 0.65317777 |
| 137 | MP0005499_abnormal_olfactory_system | 0.64712796 |
| 138 | MP0005394_taste/olfaction_phenotype | 0.64712796 |
| 139 | MP0002168_other_aberrant_phenotype | 0.64690315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.17549848 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.70059948 |
| 3 | Retinal atrophy (HP:0001105) | 4.66230484 |
| 4 | Arthropathy (HP:0003040) | 4.56128205 |
| 5 | Neuroendocrine neoplasm (HP:0100634) | 4.52662222 |
| 6 | Abnormal hair whorl (HP:0010721) | 4.52304960 |
| 7 | Wrist flexion contracture (HP:0001239) | 4.41096118 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.14570801 |
| 9 | Symptomatic seizures (HP:0011145) | 4.06106804 |
| 10 | Agitation (HP:0000713) | 4.03631882 |
| 11 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.95510864 |
| 12 | Pheochromocytoma (HP:0002666) | 3.91078817 |
| 13 | Hypomagnesemia (HP:0002917) | 3.85081192 |
| 14 | Hypoglycemic seizures (HP:0002173) | 3.74698297 |
| 15 | Visual hallucinations (HP:0002367) | 3.59099270 |
| 16 | Focal motor seizures (HP:0011153) | 3.56086105 |
| 17 | Failure to thrive in infancy (HP:0001531) | 3.48361914 |
| 18 | Oligomenorrhea (HP:0000876) | 3.48262840 |
| 19 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.47681884 |
| 20 | Atonic seizures (HP:0010819) | 3.43253526 |
| 21 | Abnormality of magnesium homeostasis (HP:0004921) | 3.29864004 |
| 22 | Acute necrotizing encephalopathy (HP:0006965) | 3.21541221 |
| 23 | Sex reversal (HP:0012245) | 3.19998792 |
| 24 | Abnormal sex determination (HP:0012244) | 3.19998792 |
| 25 | Abnormality of the fovea (HP:0000493) | 3.17830119 |
| 26 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.17302905 |
| 27 | Absence seizures (HP:0002121) | 3.10227534 |
| 28 | Hyperglycemia (HP:0003074) | 3.05964916 |
| 29 | Papilledema (HP:0001085) | 3.04803674 |
| 30 | Anterior segment dysgenesis (HP:0007700) | 3.04550964 |
| 31 | Epileptiform EEG discharges (HP:0011182) | 2.98865697 |
| 32 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.98657755 |
| 33 | EEG with generalized epileptiform discharges (HP:0011198) | 2.97672236 |
| 34 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.96460339 |
| 35 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.96460339 |
| 36 | Generalized tonic-clonic seizures (HP:0002069) | 2.94141298 |
| 37 | Hypsarrhythmia (HP:0002521) | 2.91043717 |
| 38 | Ketoacidosis (HP:0001993) | 2.90621479 |
| 39 | Osteomalacia (HP:0002749) | 2.89985653 |
| 40 | Abnormality of macular pigmentation (HP:0008002) | 2.87771551 |
| 41 | Congenital primary aphakia (HP:0007707) | 2.86638005 |
| 42 | Resting tremor (HP:0002322) | 2.85653074 |
| 43 | Adrenal hypoplasia (HP:0000835) | 2.83773554 |
| 44 | Anxiety (HP:0000739) | 2.81501735 |
| 45 | Congenital glaucoma (HP:0001087) | 2.78753181 |
| 46 | Large for gestational age (HP:0001520) | 2.76470950 |
| 47 | Delayed puberty (HP:0000823) | 2.75919586 |
| 48 | Hypoglycemic coma (HP:0001325) | 2.75428413 |
| 49 | Progressive macrocephaly (HP:0004481) | 2.74987439 |
| 50 | Focal seizures (HP:0007359) | 2.73888714 |
| 51 | Abolished electroretinogram (ERG) (HP:0000550) | 2.73295319 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.68490251 |
| 53 | Polyphagia (HP:0002591) | 2.63727492 |
| 54 | Myokymia (HP:0002411) | 2.63707988 |
| 55 | Acute encephalopathy (HP:0006846) | 2.58143753 |
| 56 | Nephrogenic diabetes insipidus (HP:0009806) | 2.56531842 |
| 57 | Dialeptic seizures (HP:0011146) | 2.54180837 |
| 58 | Late onset (HP:0003584) | 2.51795687 |
| 59 | Vaginal atresia (HP:0000148) | 2.49079416 |
| 60 | Spastic tetraplegia (HP:0002510) | 2.45980057 |
| 61 | Genital tract atresia (HP:0001827) | 2.42570029 |
| 62 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.41043077 |
| 63 | Abnormal ciliary motility (HP:0012262) | 2.39717968 |
| 64 | Hypoventilation (HP:0002791) | 2.39550178 |
| 65 | Progressive neurologic deterioration (HP:0002344) | 2.39193314 |
| 66 | Skin nodule (HP:0200036) | 2.38717197 |
| 67 | Ketosis (HP:0001946) | 2.34524596 |
| 68 | Hepatoblastoma (HP:0002884) | 2.33513035 |
| 69 | Abnormality of the labia minora (HP:0012880) | 2.30655709 |
| 70 | Genetic anticipation (HP:0003743) | 2.30619886 |
| 71 | Growth hormone deficiency (HP:0000824) | 2.29465007 |
| 72 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.29426951 |
| 73 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.29426951 |
| 74 | Mitochondrial inheritance (HP:0001427) | 2.29366438 |
| 75 | Psychosis (HP:0000709) | 2.29258860 |
| 76 | Broad face (HP:0000283) | 2.28839299 |
| 77 | Narrow nasal bridge (HP:0000446) | 2.26531564 |
| 78 | Hyperphosphaturia (HP:0003109) | 2.26260250 |
| 79 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.24685271 |
| 80 | Hypokalemia (HP:0002900) | 2.24049526 |
| 81 | Type II lissencephaly (HP:0007260) | 2.22041037 |
| 82 | Restlessness (HP:0000711) | 2.22011895 |
| 83 | Postural tremor (HP:0002174) | 2.21653273 |
| 84 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.17207627 |
| 85 | Prominent metopic ridge (HP:0005487) | 2.14779762 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.14087679 |
| 87 | Hyperparathyroidism (HP:0000843) | 2.14012115 |
| 88 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.13539311 |
| 89 | Congenital sensorineural hearing impairment (HP:0008527) | 2.13531969 |
| 90 | Hypogonadotrophic hypogonadism (HP:0000044) | 2.12249780 |
| 91 | Abnormal drinking behavior (HP:0030082) | 2.12179550 |
| 92 | Polydipsia (HP:0001959) | 2.12179550 |
| 93 | Progressive cerebellar ataxia (HP:0002073) | 2.11165200 |
| 94 | Prominent supraorbital ridges (HP:0000336) | 2.09938573 |
| 95 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.08885176 |
| 96 | Poor suck (HP:0002033) | 2.07920406 |
| 97 | Epileptic encephalopathy (HP:0200134) | 2.05741981 |
| 98 | Shoulder girdle muscle weakness (HP:0003547) | 2.05480744 |
| 99 | Buphthalmos (HP:0000557) | 2.05435876 |
| 100 | Abnormality of the vocal cords (HP:0008777) | 2.05239847 |
| 101 | Decreased circulating renin level (HP:0003351) | 2.04249251 |
| 102 | Abnormal eating behavior (HP:0100738) | 2.02537041 |
| 103 | Absent eyebrow (HP:0002223) | 2.02462920 |
| 104 | Sleep apnea (HP:0010535) | 2.02117897 |
| 105 | Hepatic necrosis (HP:0002605) | 2.02059533 |
| 106 | Tachypnea (HP:0002789) | 2.01476207 |
| 107 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.01195953 |
| 108 | Unilateral renal agenesis (HP:0000122) | 2.00891734 |
| 109 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.00838232 |
| 110 | Hypothermia (HP:0002045) | 2.00788232 |
| 111 | Abnormality of pain sensation (HP:0010832) | 1.99710128 |
| 112 | Impaired pain sensation (HP:0007328) | 1.99710128 |
| 113 | Azoospermia (HP:0000027) | 1.99209731 |
| 114 | Macroorchidism (HP:0000053) | 1.98375295 |
| 115 | Gait imbalance (HP:0002141) | 1.96771083 |
| 116 | Congenital stationary night blindness (HP:0007642) | 1.96094795 |
| 117 | Renal salt wasting (HP:0000127) | 1.95744823 |
| 118 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.95137129 |
| 119 | Tetany (HP:0001281) | 1.94900032 |
| 120 | Gout (HP:0001997) | 1.94681225 |
| 121 | Intestinal atresia (HP:0011100) | 1.94027205 |
| 122 | Tubulointerstitial nephritis (HP:0001970) | 1.94027052 |
| 123 | Labial hypoplasia (HP:0000066) | 1.93141090 |
| 124 | Lissencephaly (HP:0001339) | 1.91721176 |
| 125 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.90770977 |
| 126 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.90770977 |
| 127 | Depression (HP:0000716) | 1.90569158 |
| 128 | 3-Methylglutaconic aciduria (HP:0003535) | 1.90424218 |
| 129 | Renal Fanconi syndrome (HP:0001994) | 1.89916291 |
| 130 | Torticollis (HP:0000473) | 1.89567341 |
| 131 | Abnormal pupillary function (HP:0007686) | 1.89528727 |
| 132 | Poor coordination (HP:0002370) | 1.89453154 |
| 133 | Broad-based gait (HP:0002136) | 1.89017797 |
| 134 | Polyuria (HP:0000103) | 1.89003584 |
| 135 | Rhinitis (HP:0012384) | 1.88870220 |
| 136 | Mesomelia (HP:0003027) | 1.88751337 |
| 137 | Hyperventilation (HP:0002883) | 1.87417483 |
| 138 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.87333180 |
| 139 | Absent/shortened dynein arms (HP:0200106) | 1.87333180 |
| 140 | Retinitis pigmentosa (HP:0000510) | 1.87188678 |
| 141 | Hyperphosphatemia (HP:0002905) | 1.85793073 |
| 142 | Specific learning disability (HP:0001328) | 1.85071329 |
| 143 | Abnormal pancreas size (HP:0012094) | 1.84980514 |
| 144 | Muscular hypotonia of the trunk (HP:0008936) | 1.84964049 |
| 145 | Generalized hypopigmentation (HP:0007513) | 1.84386916 |
| 146 | Drooling (HP:0002307) | 1.84345633 |
| 147 | Excessive salivation (HP:0003781) | 1.84345633 |
| 148 | Retinal dysplasia (HP:0007973) | 1.83756193 |
| 149 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.83237795 |
| 150 | Hypoplasia of the fovea (HP:0007750) | 1.83237795 |
| 151 | Short foot (HP:0001773) | 1.82626856 |
| 152 | Tinnitus (HP:0000360) | 1.82616352 |
| 153 | Abnormal urine phosphate concentration (HP:0012599) | 1.82235252 |
| 154 | Increased circulating renin level (HP:0000848) | 1.81693754 |
| 155 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.81389232 |
| 156 | Abnormality of the diencephalon (HP:0010662) | 1.80173101 |
| 157 | Neuronal loss in central nervous system (HP:0002529) | 1.80019705 |
| 158 | Zonular cataract (HP:0010920) | 1.79881166 |
| 159 | Abnormality of dental color (HP:0011073) | 1.79772159 |
| 160 | Medial flaring of the eyebrow (HP:0010747) | 1.78394831 |
| 161 | Febrile seizures (HP:0002373) | 1.78205988 |
| 162 | Focal dystonia (HP:0004373) | 1.74406301 |
| 163 | Attenuation of retinal blood vessels (HP:0007843) | 1.73172421 |
| 164 | Abnormality of renin-angiotensin system (HP:0000847) | 1.73151235 |
| 165 | Absent speech (HP:0001344) | 1.72789377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 6.92692132 |
| 2 | TAOK3 | 4.37457883 |
| 3 | PIK3CG | 3.82310200 |
| 4 | INSRR | 3.52948198 |
| 5 | NTRK3 | 2.96170219 |
| 6 | HIPK2 | 2.65242606 |
| 7 | MAP3K4 | 2.62939671 |
| 8 | UHMK1 | 2.56448388 |
| 9 | MAP2K7 | 2.50514600 |
| 10 | CASK | 2.37015660 |
| 11 | PNCK | 2.36957395 |
| 12 | MAP3K12 | 2.31634169 |
| 13 | STK16 | 2.27849766 |
| 14 | MYLK | 2.17373821 |
| 15 | FRK | 2.15870157 |
| 16 | NME1 | 2.10234962 |
| 17 | MAP3K2 | 2.09666359 |
| 18 | AKT3 | 2.06634768 |
| 19 | MAPK15 | 2.05186058 |
| 20 | NTRK2 | 2.01606004 |
| 21 | MAP3K9 | 1.95129819 |
| 22 | PAK3 | 1.86805543 |
| 23 | ARAF | 1.84596498 |
| 24 | GRK7 | 1.80216685 |
| 25 | PASK | 1.66415839 |
| 26 | MARK1 | 1.66049946 |
| 27 | PRKD3 | 1.61856116 |
| 28 | TAOK1 | 1.60471871 |
| 29 | TESK1 | 1.58444471 |
| 30 | DYRK2 | 1.53790393 |
| 31 | MAP2K4 | 1.49197033 |
| 32 | ADRBK2 | 1.44877072 |
| 33 | MAP4K2 | 1.41894981 |
| 34 | ERBB3 | 1.41740093 |
| 35 | TESK2 | 1.38994512 |
| 36 | WNK3 | 1.38783660 |
| 37 | MAPKAPK3 | 1.38203667 |
| 38 | MAP3K1 | 1.34990256 |
| 39 | KSR2 | 1.34063312 |
| 40 | GRK1 | 1.32774470 |
| 41 | MINK1 | 1.29576682 |
| 42 | NTRK1 | 1.22478690 |
| 43 | TRIM28 | 1.15689734 |
| 44 | CAMK2A | 1.15368746 |
| 45 | BRAF | 1.13777822 |
| 46 | PRKCH | 1.11189413 |
| 47 | CAMK2B | 1.07757426 |
| 48 | CDC42BPA | 1.07388545 |
| 49 | PRKCG | 1.03475608 |
| 50 | NLK | 1.00652799 |
| 51 | SCYL2 | 1.00073230 |
| 52 | GRK5 | 1.00041860 |
| 53 | PRKCE | 0.98002631 |
| 54 | MAP3K13 | 0.95915963 |
| 55 | CAMK2D | 0.94753012 |
| 56 | CDK5 | 0.94188857 |
| 57 | CAMK2G | 0.91147990 |
| 58 | EPHA3 | 0.88568568 |
| 59 | CAMK1 | 0.88363542 |
| 60 | PLK2 | 0.87141065 |
| 61 | MAP2K1 | 0.86584645 |
| 62 | CSNK1A1 | 0.85646960 |
| 63 | MAPK13 | 0.83605220 |
| 64 | ADRBK1 | 0.78248583 |
| 65 | BCR | 0.73362943 |
| 66 | CAMK4 | 0.72661375 |
| 67 | DAPK1 | 0.72368551 |
| 68 | OXSR1 | 0.72137802 |
| 69 | RPS6KL1 | 0.68410096 |
| 70 | RPS6KC1 | 0.68410096 |
| 71 | SGK494 | 0.67983273 |
| 72 | SGK223 | 0.67983273 |
| 73 | RPS6KA2 | 0.67068075 |
| 74 | FES | 0.66747857 |
| 75 | FER | 0.65423997 |
| 76 | MARK2 | 0.65172051 |
| 77 | CSNK1G2 | 0.64770113 |
| 78 | CAMK1G | 0.64389461 |
| 79 | CSNK1A1L | 0.64065125 |
| 80 | CAMKK2 | 0.63883545 |
| 81 | CSNK1G3 | 0.63369617 |
| 82 | PRKACB | 0.62084862 |
| 83 | SIK3 | 0.61340214 |
| 84 | PAK6 | 0.60413229 |
| 85 | WNK4 | 0.59804902 |
| 86 | LIMK1 | 0.58779508 |
| 87 | SGK2 | 0.57741827 |
| 88 | PRKACA | 0.57039931 |
| 89 | GSK3A | 0.56738497 |
| 90 | CDK3 | 0.55535197 |
| 91 | BMPR2 | 0.55123270 |
| 92 | EIF2AK3 | 0.54951524 |
| 93 | PTK2 | 0.54446776 |
| 94 | MAP2K6 | 0.53295251 |
| 95 | PRKCZ | 0.51326135 |
| 96 | MAP3K7 | 0.50488032 |
| 97 | BMPR1B | 0.48745329 |
| 98 | STK11 | 0.48130525 |
| 99 | PRKACG | 0.48065905 |
| 100 | ALK | 0.47979440 |
| 101 | PIK3CA | 0.47136044 |
| 102 | IRAK1 | 0.46854934 |
| 103 | ZAK | 0.45595813 |
| 104 | RPS6KA6 | 0.45447445 |
| 105 | DAPK2 | 0.45169080 |
| 106 | KSR1 | 0.45129939 |
| 107 | RET | 0.45046051 |
| 108 | TSSK6 | 0.43792138 |
| 109 | ERBB4 | 0.43223081 |
| 110 | DAPK3 | 0.42791888 |
| 111 | MAPK9 | 0.42609996 |
| 112 | PHKG1 | 0.42240531 |
| 113 | PHKG2 | 0.42240531 |
| 114 | DYRK3 | 0.41929582 |
| 115 | PRKCA | 0.41768246 |
| 116 | PKN1 | 0.41568825 |
| 117 | BCKDK | 0.41188939 |
| 118 | PRKCQ | 0.40884216 |
| 119 | PRKCI | 0.39755724 |
| 120 | SGK1 | 0.39594540 |
| 121 | WNK1 | 0.39508454 |
| 122 | CAMKK1 | 0.38774284 |
| 123 | RPS6KA3 | 0.38659166 |
| 124 | PRKCB | 0.38190683 |
| 125 | CSNK1D | 0.37729169 |
| 126 | CSNK1E | 0.37597149 |
| 127 | RPS6KA5 | 0.37540110 |
| 128 | RIPK4 | 0.36846366 |
| 129 | ACVR1B | 0.36492136 |
| 130 | PRKG1 | 0.36491730 |
| 131 | PTK6 | 0.35813007 |
| 132 | CSNK1G1 | 0.35592794 |
| 133 | CHUK | 0.34931670 |
| 134 | LMTK2 | 0.34881534 |
| 135 | EPHA4 | 0.34310335 |
| 136 | STK38L | 0.31443549 |
| 137 | FGFR2 | 0.31388116 |
| 138 | FLT3 | 0.28714112 |
| 139 | ABL1 | 0.24962670 |
| 140 | EPHB1 | 0.24789056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.97599393 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.64294419 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.96427757 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.94591131 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.76500242 |
| 6 | Insulin secretion_Homo sapiens_hsa04911 | 2.71296084 |
| 7 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.71198390 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.65690105 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.24835340 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.14378588 |
| 11 | Nicotine addiction_Homo sapiens_hsa05033 | 2.14004863 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.08604166 |
| 13 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.97892517 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 1.94335751 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.91589009 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.87823590 |
| 17 | Alzheimers disease_Homo sapiens_hsa05010 | 1.82827708 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.81105880 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.80708981 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.78832460 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.75045584 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.73485360 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.71850075 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.71343714 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.70905144 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.59721564 |
| 27 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.57052586 |
| 28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.56010561 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.54671192 |
| 30 | Long-term potentiation_Homo sapiens_hsa04720 | 1.50954299 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.47218238 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.45973611 |
| 33 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.42920886 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.41127975 |
| 35 | Phototransduction_Homo sapiens_hsa04744 | 1.35363339 |
| 36 | Olfactory transduction_Homo sapiens_hsa04740 | 1.34334084 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.33998027 |
| 38 | Salivary secretion_Homo sapiens_hsa04970 | 1.33988652 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.32561811 |
| 40 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.29260346 |
| 41 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.27728398 |
| 42 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.26721100 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24544151 |
| 44 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.23673895 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.21520968 |
| 46 | Huntingtons disease_Homo sapiens_hsa05016 | 1.17771303 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.13907839 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.09159338 |
| 49 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.06632207 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.06435338 |
| 51 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.06372562 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05895860 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.05818291 |
| 54 | Peroxisome_Homo sapiens_hsa04146 | 1.02704300 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01156718 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01039014 |
| 57 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.00616074 |
| 58 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.98847056 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97359598 |
| 60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97064230 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.91521412 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.90294533 |
| 63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88944054 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88637550 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 0.88419258 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.87820661 |
| 67 | * Gastric acid secretion_Homo sapiens_hsa04971 | 0.87776413 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.82423587 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80552482 |
| 70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79674816 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78918058 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.77764060 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77273938 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75755334 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74436803 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.73805149 |
| 77 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73542400 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68404283 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.65623158 |
| 80 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.62149521 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61929895 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61729862 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59039595 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58105453 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57590893 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57428812 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57098963 |
| 88 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52600625 |
| 89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52055580 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51907813 |
| 91 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51745280 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.51191988 |
| 93 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50482319 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48733321 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48072465 |
| 96 | RNA degradation_Homo sapiens_hsa03018 | 0.46698547 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46509254 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45801369 |
| 99 | Melanogenesis_Homo sapiens_hsa04916 | 0.45620300 |
| 100 | RNA polymerase_Homo sapiens_hsa03020 | 0.44266231 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43692032 |
| 102 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.43590285 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.42665226 |
| 104 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42491672 |
| 105 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42069978 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41062308 |
| 107 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.40752005 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39372308 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38778044 |
| 110 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.38522866 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.35558750 |
| 112 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.34669994 |
| 113 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.34327823 |
| 114 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30642701 |
| 115 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30083644 |
| 116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28465014 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27819340 |
| 118 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26511494 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.23802302 |
| 120 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.23294656 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.22441119 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22354615 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22343058 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22316393 |
| 125 | Histidine metabolism_Homo sapiens_hsa00340 | 0.22192709 |
| 126 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.19197630 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18708608 |
| 128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.16769323 |
| 129 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.16462693 |
| 130 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.16179867 |
| 131 | Circadian rhythm_Homo sapiens_hsa04710 | 0.15298978 |
| 132 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.15031325 |
| 133 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.14978768 |
| 134 | Glioma_Homo sapiens_hsa05214 | 0.14231461 |
| 135 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.13678344 |
| 136 | Bile secretion_Homo sapiens_hsa04976 | 0.12789150 |
| 137 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.12024269 |

